Fagron N.V. Logo

Fagron N.V.

ISIN: BE0003874915 | Ticker: FAGR
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Belgium

About Fagron N.V.

Company Description

Fagron is active in 35 countries in EMEA, North America, and Latin America. Fagron has sterile and non-sterile compounding facilities in Europe (the Netherlands, Belgium, and the Czech Republic), Israel, the United States, Colombia, and South Africa, which supply medications to pharmacies, hospitals, and clinics, as well as directly to patients in South Africa and Colombia.

With over 400 pharmacists within Fagron, we are focused on providing a unique range of high-quality products based on scientific data and insights. The Fagron Brands are unique concepts developed by our R&D specialists to provide pharmacies and clients with exclusive pharmaceutical dosage forms and active pharmaceutical ingredients (APIs). We can provide solutions for all steps inside a compounding setting, either equipment, excipients, APIs, packaging, and much more.

Year founded


Served area



Venecoweg 20A, 9810 Nazareth, Oost-Vlaanderen – Belgium

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
19.12.23 AOC Pharma S.à r.l. Close relation Buy EUR 16,500,000.00
05.12.23 AOC Pharma S.à r.l. Close relation Buy EUR 3,001,250.00
20.10.23 AOC Pharma S.à r.l. Close relation Buy EUR 7,748.65
19.10.23 De Jong Cornelia Neeltje Board Buy EUR 38,750.00
04.08.22 Padilla Rafael Board Buy EUR 49,945.00
03.12.21 De Jong Cornelia Neeltje Board Buy EUR 27,280.00
02.12.21 De Jong Cornelia Neeltje Board Buy EUR 33,250.00
01.12.21 Van Rietschoten Constantijn Executive member Buy EUR 33,375.00
30.11.21 Verlinden Johan Executive member Buy EUR 66,199.70
30.11.21 Padilla Rafael Board Buy EUR 49,899.50

Capital markets information




Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences





Listed Stock Exchange

Euronext Brussels

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.